Matthew D. Hall

1.7k total citations
96 papers, 804 citations indexed

About

Matthew D. Hall is a scholar working on Pulmonary and Respiratory Medicine, Genetics and Oncology. According to data from OpenAlex, Matthew D. Hall has authored 96 papers receiving a total of 804 indexed citations (citations by other indexed papers that have themselves been cited), including 53 papers in Pulmonary and Respiratory Medicine, 31 papers in Genetics and 29 papers in Oncology. Recurrent topics in Matthew D. Hall's work include Glioma Diagnosis and Treatment (30 papers), Advanced Radiotherapy Techniques (28 papers) and Brain Metastases and Treatment (19 papers). Matthew D. Hall is often cited by papers focused on Glioma Diagnosis and Treatment (30 papers), Advanced Radiotherapy Techniques (28 papers) and Brain Metastases and Treatment (19 papers). Matthew D. Hall collaborates with scholars based in United States, United Kingdom and Canada. Matthew D. Hall's co-authors include Timothy E. Schultheiss, Jeffrey Y.C. Wong, Rupesh Kotecha, Minesh P. Mehta, Alonso N. Gutiérrez, Michael D. Chuong, Muni Rubens, David Smith, Kathryn E. Mittauer and Diane Alvarez and has published in prestigious journals such as Journal of Clinical Oncology, Gastroenterology and Neurology.

In The Last Decade

Matthew D. Hall

85 papers receiving 796 citations

Peers

Matthew D. Hall
D.N. Yeboa United States
Kristin Bradley United States
Fadıl Akyol Türkiye
Rami A. El Shafie Germany
A. Yuriko Minn United States
Jeremy Ruben Australia
Silke Engelholm Sweden
Aaron Brown United States
Michael Farris United States
Gözde Yazıcı Türkiye
D.N. Yeboa United States
Matthew D. Hall
Citations per year, relative to Matthew D. Hall Matthew D. Hall (= 1×) peers D.N. Yeboa

Countries citing papers authored by Matthew D. Hall

Since Specialization
Citations

This map shows the geographic impact of Matthew D. Hall's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Matthew D. Hall with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Matthew D. Hall more than expected).

Fields of papers citing papers by Matthew D. Hall

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Matthew D. Hall. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Matthew D. Hall. The network helps show where Matthew D. Hall may publish in the future.

Co-authorship network of co-authors of Matthew D. Hall

This figure shows the co-authorship network connecting the top 25 collaborators of Matthew D. Hall. A scholar is included among the top collaborators of Matthew D. Hall based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Matthew D. Hall. Matthew D. Hall is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tolakanahalli, Ranjini, Yanjia Zhang, Matthew D. Hall, et al.. (2025). Quantifying risk of radiation necrosis: Normal tissue complication probability modeling following stereotactic radiosurgery for small brain metastases in the modern era. Radiotherapy and Oncology. 214. 111266–111266.
2.
3.
Baruteau, Julien, Anil Dhawan, Anupam Chakrapani, et al.. (2025). P008: A first in human, single arm, open label phase 1/2 study evaluating ECUR-506 in neonatal OTC Deficiency: Initial Observations. Genetics in Medicine Open. 3. 102852–102852. 1 indexed citations
4.
Hall, Matthew D., Robert H. Press, Andrew Wroe, et al.. (2025). Proton Craniospinal Irradiation for Patients with Solid Tumor Leptomeningeal Disease: Real-World Feasibility, Toxicity, and Outcome Analysis. Cancers. 17(6). 1046–1046.
5.
Zerey, Marc, et al.. (2025). Hypofractionated Radiotherapy for Soft Tissue Sarcomas. Cancers. 17(7). 1170–1170.
6.
7.
Odia, Yazmín, et al.. (2024). An Update on H3K27M-altered Diffuse Midline Glioma: Diagnostic and Therapeutic Challenges in Clinical Practice. Practical Radiation Oncology. 14(5). 443–451. 2 indexed citations
8.
Chuong, Michael D., Muni Rubens, Rupesh Kotecha, et al.. (2024). Lymphopenia and spleen dose for patients with inoperable pancreatic cancer receiving ablative 5-fraction radiation therapy.. Journal of Clinical Oncology. 42(3_suppl). 686–686.
9.
Mittauer, Kathryn E., Michael D. Chuong, Matthew D. Hall, et al.. (2023). Accelerated hypofractionated magnetic resonance-guided adaptive radiotherapy for oligoprogressive non-small cell lung cancer. Medical dosimetry. 48(4). 238–244. 3 indexed citations
10.
Tom, Martin C., Tuğçe Kütük, Muni Rubens, et al.. (2023). Characterization of Large Brain Metastases with 18F-Fluciclovine PET/CT Treated with Staged Stereotactic Radiosurgery (SSRS): Phase 1 Proof-of-Concept Interim Analysis. International Journal of Radiation Oncology*Biology*Physics. 117(2). e119–e120. 1 indexed citations
11.
Gutiérrez, Alonso N., Kathryn E. Mittauer, James McCulloch, et al.. (2023). PO-1670 Initial Assessment of Adaptive Pancreas SBRT Treatment Efficiency using ViewRay MRIdian A3i. Radiotherapy and Oncology. 182. S1373–S1374.
12.
Odia, Yazmín, Anshul Saxena, Mukesh Roy, et al.. (2023). Evaluating the diagnostic performance of leptomeningeal diagnosis with CNSide compared to standard cytology.. Journal of Clinical Oncology. 41(16_suppl). 2028–2028. 1 indexed citations
13.
Kütük, Tuğçe, et al.. (2023). Dose-Escalated Preoperative Proton Therapy for Retroperitoneal Sarcomas: Initial Outcomes of a New Treatment Paradigm. Advances in Radiation Oncology. 9(4). 101431–101431. 1 indexed citations
14.
Kalman, Noah S., Ramon E. Jimenez, Robert H. Press, et al.. (2023). Multi-Institutional Experience of Proton Therapy for Osteosarcoma in the Proton Collaborative Group (PCG) Prospective Registry. International Journal of Radiation Oncology*Biology*Physics. 117(2). e322–e322. 1 indexed citations
15.
Hall, Matthew D., Kathryn E. Mittauer, Rupesh Kotecha, et al.. (2023). Initial clinical experience with magnetic resonance-guided radiotherapy in pediatric patients: Lessons learned from a single institution with proton therapy. Frontiers in Oncology. 12. 1037674–1037674. 1 indexed citations
16.
Seravalli, Enrica, P.S. Kroon, John M. Buatti, et al.. (2021). The potential role of MR-guided adaptive radiotherapy in pediatric oncology: Results from a SIOPE-COG survey. Clinical and Translational Radiation Oncology. 29. 71–78. 9 indexed citations
17.
Chuong, Michael D., Rupesh Kotecha, Minesh P. Mehta, et al.. (2021). Case report of visual biofeedback-driven, magnetic resonance-guided single-fraction SABR in breath hold for early stage non–small-cell lung cancer. Medical dosimetry. 46(3). 247–252. 6 indexed citations
18.
Kotecha, Rupesh, Muni Rubens, Michael D. Chuong, et al.. (2020). A Comprehensive Analysis of a Prospective Multidisciplinary Peer Review Process Before Radiation Therapy Simulation. Practical Radiation Oncology. 11(4). e366–e375. 3 indexed citations
19.
Chuong, Michael D., John Michael Bryant, Kathryn E. Mittauer, et al.. (2020). Ablative 5-Fraction Stereotactic Magnetic Resonance–Guided Radiation Therapy With On-Table Adaptive Replanning and Elective Nodal Irradiation for Inoperable Pancreas Cancer. Practical Radiation Oncology. 11(2). 134–147. 113 indexed citations
20.
Indelicato, Daniel J., Julie A. Bradley, Ronny L. Rotondo, et al.. (2016). Single-Institution Outcomes Following Proton Therapy for Children With Central Nervous System Tumors Referred Overseas. International Journal of Radiation Oncology*Biology*Physics. 96(2). E551–E551. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by D.N. Yeboa Breakdown of academic impact, for papers by Kristin Bradley Breakdown of academic impact, for papers by Fadıl Akyol Breakdown of academic impact, for papers by Rami A. El Shafie Breakdown of academic impact, for papers by A. Yuriko Minn Breakdown of academic impact, for papers by Jeremy Ruben Breakdown of academic impact, for papers by Silke Engelholm Breakdown of academic impact, for papers by Aaron Brown Breakdown of academic impact, for papers by Michael Farris Breakdown of academic impact, for papers by Gözde Yazıcı
Rankless by CCL
2026